TS
RMD icon

Triglav Skladi’s ResMed RMD Stock Holding History

Triglav Skladi’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25M Hold
6,400
– – 0.07% 131
2026
Q1 		$1.44M Hold
6,400
– – 0.1% 108
2025
Q4 		$1.54M Sell
6,400
-1,000
-14% -$256K 0.1% 105
2025
Q3 		$2.03M Hold
7,400
– – 0.13% 78
2025
Q2 		$1.91M Hold
7,400
– – 0.14% 79
2025
Q1 		$1.66M Hold
7,400
– – 0.14% 80
2024
Q4 		$1.69M Buy
+7,400
New +$1.78M 0.13% 80

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Triglav Skladi's RMD Position: Q2 2026 in Review

Triglav Skladi held its ResMed (RMD) position steady in Q2 2026 at 6,400 shares worth $1.25M. The position accounts for 0.07% of the portfolio, ranked #131.

Triglav Skladi first reported a position in RMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.03M in Q3 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Triglav Skladi held 6,400 shares of ResMed worth $1.25M as of Q2 2026.
  • Triglav Skladi left its ResMed share count unchanged in Q2 2026.
  • ResMed made up 0.07% of Triglav Skladi's portfolio in Q2 2026, its #131 holding.
  • Triglav Skladi first reported a position in ResMed in Q4 2024 and has held it in 7 quarters since.
  • Triglav Skladi's ResMed position peaked at $2.03M in Q3 2025.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Triglav Skladi's 13F filing for Q2 2026, filed 11 Aug 2026.